BioProcess International: CDMOs are now the leaders in the biomanufacturing space

Published: 2 August 2021 Author: Roger Lias, Ph.D., Chief Commercial Officer

Roger Lias, PhD, Chief Commercial Officer recently sat down with BioProcess International to discuss how “CDMOs are now the leaders in the biomanufacturing space”.

To read the BioProcess International article:

We’re the ideal CDMO for your Virotherapy project

Get in touch


Looking for something different?

Vibalogics can assist you through a comprehensive service portfolio – ensuring success of your virotherapy, beginning with process development and technical transfer feasibility, through cGMP production and validation.


What to read next

Time to Outsource Viral Vector Development

A fast-growing sector The outsourcing of process development, manufacturing, and analytical testing i…

The Advantage of Engaging Your CDMO Early

One of the key things that I have learned from my many years in the biopharma market is that it is not…

Top Tips in Selecting your Viral Vector Partner

From cutting-edge therapies for deadly cancers, to developing effective vaccines, the viral vector spa…